目次

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Pharmaceutical Contract Manufacturing Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Patent Expiry and Increasing Demand for Generic Drugs
3.2.1.2 Increasing Investments in Pharmaceutical R&D
3.2.1.3 Investments in Advanced Manufacturing Technologies by CDMOs
3.2.2 Market Restraining Factors
3.2.2.1 Introduction of Serialization
3.2.3 Market Opportunities
3.2.3.1 Increasing Demand for Biological Therapies
3.2.3.2 Growth in the Nuclear Medicine Sector
3.2.3.3 Growing Demand for Cell and Gene Therapies
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Supplier
3.4.2 Bargaining Power of Buyer
3.4.3 Threat of New Entrants
3.4.4 Threat of Substitutes
3.4.5 Competitive Rivalry
3.5 PEST Analysis
3.6 SWOT Analysis

4 Pharmaceutical Contract Manufacturing Market, by Services, 2023-2033
4.1 Key Findings
4.2 Services Segment: Market Attractiveness Index
4.3 Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Services
4.4 Pharmaceutical Manufacturing Services
4.4.1 Market Size by Region, 2023-2033 (US$ bn)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.4.3 Pharmaceutical API Manufacturing Services
4.4.3.1 Market Size by Region, 2023-2033 (US$ bn)
4.4.3.2 Market Share by Region, 2023 & 2033 (%)
4.4.4 Pharmaceutical FDF Manufacturing Services
4.4.4.1 Market Size by Region, 2023-2033 (US$ bn)
4.4.4.2 Market Share by Region, 2023 & 2033 (%)
4.4.4.3 Parenteral/Injectable Manufacturing Services
4.4.4.4 Tablet Manufacturing Services
4.4.4.5 Capsule Manufacturing Services
4.4.4.6 Oral Liquid Manufacturing Services
4.4.4.7 Semi-solid Manufacturing Services
4.4.4.8 Other Formulation Manufacturing Services
4.5 Drug Development Services
4.5.1 Market Size by Region, 2023-2033 (US$ bn)
4.5.2 Market Share by Region, 2023 & 2033 (%)
4.5.3 Lead Identification & Candidate Optimization
4.5.3.1 Market Size by Region, 2023-2033 (US$ bn)
4.5.3.2 Market Share by Region, 2023 & 2033 (%)
4.5.4 Target Identification & Screening
4.5.4.1 Market Size by Region, 2023 - 2033 (US$bn)
4.5.4.2 Market Share by Region, 2023 & 2033 (%)
4.5.5 Target Validation & Functional Informatics
4.5.5.1 Market Size by Region, 2023 - 2033 (US$bn)
4.5.5.2 Market Share by Region, 2023 & 2033 (%)
4.5.6 Other Services
4.5.6.1 Market Size by Region, 2023 - 2033 (US$bn)
4.5.6.2 Market Share by Region, 2023 & 2033 (%)
4.6 Biologics Manufacturing Services
4.6.1 Market Size by Region, 2023-2033 (US$ bn)
4.6.2 Market Share by Region, 2023 & 2033 (%)
4.6.3 Biologics API Manufacturing Services
4.6.3.1 Market Size by Region, 2023-2033 (US$ bn)
4.6.3.2 Market Share by Region, 2023 & 2033 (%)
4.6.4 Biologics FDF Manufacturing Services
4.6.4.1 Market Size by Region, 2023-2033 (US$ bn)
4.6.4.2 Market Share by Region, 2023 & 2033 (%)

5 Pharmaceutical Contract Manufacturing Market, by End-users, 2023-2033
5.1 Key Findings
5.2 End-users Segment: Market Attractiveness Index
5.3 Pharmaceutical Contract Manufacturing Market, by End-users
5.4 Big Pharmaceutical Companies
5.4.1 Market Size by Region, 2023-2033 (US$ bn)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Small & Medium-Sized Pharmaceutical Companies
5.5.1 Market Size by Region, 2023-2033 (US$ bn)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Generic Pharmaceutical Company
5.6.1 Market Size by Region, 2023-2033 (US$ bn)
5.6.2 Market Share by Region, 2023 & 2033 (%)
5.7 Other End-users
5.7.1 Market Size by Region, 2023-2033 (US$ bn)
5.7.2 Market Share by Region, 2023 & 2033 (%)

6 Pharmaceutical Contract Manufacturing Market, by Drug Type, 2023-2033
6.1 Key Findings
6.2 Drug Type Segment: Market Attractiveness Index
6.3 Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Drug Type
6.4 Branded
6.4.1 Market Size by Region, 2023-2033 (US$ bn)
6.4.2 Market Share by Region, 2023 & 2033 (%)
6.5 Generic
6.5.1 Market Size by Region, 2023-2033 (US$ bn)
6.5.2 Market Share by Region, 2023 & 2033 (%)

7 Pharmaceutical Contract Manufacturing Market Analysis by Region, 2023-2033
7.1 Key Findings
7.2 Regional Market Size Estimation and Forecast

8 North America Pharmaceutical Contract Manufacturing Market, 2023-2033
8.1 Key Findings
8.2 North America Pharmaceutical Contract Manufacturing Market Attractiveness Index
8.3 North America Pharmaceutical Contract Manufacturing Market Forecast by Services
8.4 North America Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by End-users
8.5 North America Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Drug Type
8.6 North America Pharmaceutical Contract Manufacturing Market Forecast by Country
8.7 U.S. Pharmaceutical Contract Manufacturing Market Analysis
8.8 Canada Pharmaceutical Contract Manufacturing Market Analysis

9 Europe Pharmaceutical Contract Manufacturing Market, 2023-2033
9.1 Key Findings
9.2 Europe Pharmaceutical Contract Manufacturing Market Attractiveness Index
9.3 Europe Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Country
9.4 Europe Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Services
9.5 Europe Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by End-users
9.6 Europe Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Drug Type
9.7 Germany Pharmaceutical Contract Manufacturing Market Analysis
9.8 UK Pharmaceutical Contract Manufacturing Market Analysis
9.9 France Pharmaceutical Contract Manufacturing Market Analysis
9.10 Italy Pharmaceutical Contract Manufacturing Market Analysis
9.11 Spain Pharmaceutical Contract Manufacturing Market Analysis
9.12 Switzerland Pharmaceutical Contract Manufacturing Market Analysis
9.13 Rest of Europe Pharmaceutical Contract Manufacturing Market Analysis

10 Asia Pacific Pharmaceutical Contract Manufacturing Market Analysis
10.1 Key Findings
10.2 Asia Pacific Pharmaceutical Contract Manufacturing Market Attractiveness Index
10.3 Asia Pacific Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Country
10.4 Asia Pacific Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Services
10.5 Asia Pacific Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by End-users
10.6 Asia Pacific Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Drug Type
10.7 Japan Pharmaceutical Contract Manufacturing Market Analysis
10.8 China Pharmaceutical Contract Manufacturing Market Analysis
10.9 India Pharmaceutical Contract Manufacturing Market Analysis
10.10 Australia Pharmaceutical Contract Manufacturing Market Analysis
10.11 South Korea Pharmaceutical Contract Manufacturing Market Analysis
10.12 Rest of Asia Pacific Pharmaceutical Contract Manufacturing Market Analysis

11 Latin America Pharmaceutical Contract Manufacturing Market Analysis
11.1 Key Findings
11.2 Latin America Pharmaceutical Contract Manufacturing Market Attractiveness Index
11.3 Latin America Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Country
11.4 Latin America Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Services
11.5 Latin America Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by End-users
11.6 Latin America Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Drug Type
11.7 Brazil Pharmaceutical Contract Manufacturing Market Analysis
11.8 Mexico Pharmaceutical Contract Manufacturing Market Analysis
11.9 Rest of Latin America Pharmaceutical Contract Manufacturing Market Analysis

12 MEA Pharmaceutical Contract Manufacturing Market Analysis
12.1 Key Findings
12.2 MEA Pharmaceutical Contract Manufacturing Market Attractiveness Index
12.3 MEA Pharmaceutical Contract Manufacturing Market by Country, 2023, 2028 & 2033 (US$ bn)
12.4 MEA Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Country
12.5 MEA Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Services
12.6 MEA Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by End-users
12.7 MEA Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Drug Type
12.8 GCC Pharmaceutical Contract Manufacturing Market Analysis
12.9 South Africa Pharmaceutical Contract Manufacturing Market Analysis
12.10 Rest of MEA Pharmaceutical Contract Manufacturing Market Analysis

13 Company Profiles
13.1 Competitive Landscape
13.2 Lonza
13.2.1 Company Snapshot
13.2.2 Company Overview
13.2.3 Financial Analysis
13.2.3.1 Net Revenue, 2018-2022
13.2.4 Service Benchmarking
13.2.5 Strategic Outlook
13.3 Catalent, Inc
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Financial Analysis
13.3.3.1 Net Revenue, 2018-2022
13.3.3.2 Regional Market Shares, 2022
13.3.4 Service Benchmarking
13.3.5 Strategic Outlook
13.4 Recipharm AB
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Financial Analysis
13.4.3.1 Net Revenue, 2017-2021
13.4.4 Service Benchmarking
13.4.5 Strategic Outlook
13.5 AbbVie Inc.
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Financial Analysis
13.5.3.1 Net Revenue, 2018-2022
13.5.3.2 R&D, 2018-2022
13.5.3.3 Regional Market Shares, 2022
13.5.4 Service Benchmarking
13.5.5 Strategic Outlook
13.6 Thermo Fisher Scientific
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Financial Analysis
13.6.3.1 Net Revenue, 2017-2021
13.6.3.2 R&D, 2017-2021
13.6.4 Service Benchmarking
13.6.5 Strategic Outlook
13.7 Siegfried Holding AG
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Financial Analysis
13.7.3.1 Net Revenue, 2018-2022
13.7.3.2 R&D, 2018-2022
13.7.4 Service Benchmarking
13.7.5 Strategic Outlook
13.8 Evonik Industries
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Financial Analysis
13.8.3.1 Net Revenue, 2018-2022
13.8.3.2 R&D, 2018-2022
13.8.3.3 Regional Market Shares, 2022
13.8.4 Service Benchmarking
13.8.5 Strategic Outlook
13.9 Boehringer Ingelheim International GmbH
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Financial Analysis
13.9.3.1 Net Revenue, 2017-2021
13.9.3.2 R&D, 2017-2021
13.9.3.3 Regional Market Shares, 2021
13.9.4 Service Benchmarking
13.9.5 Strategic Outlook
13.10 Piramal Pharma Solutions
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Service Benchmarking
13.10.4 Strategic Outlook
13.11 Samsung Biologics
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Financial Analysis
13.11.3.1 Net Revenue, 2017-2021
13.11.3.2 Regional Market Shares, 2021
13.11.4 Service Benchmarking
13.11.5 Strategic Outlook
13.12 WuXi AppTec
13.12.1 Company Snapshot
13.12.2 Company Overview
13.12.3 Financial Analysis
13.12.3.1 Net Revenue, 2017-2021
13.12.4 Service Benchmarking
13.12.5 Strategic Outlook
13.13 FUJIFILM Holdings Corporation
13.13.1 Company Snapshot
13.13.2 Company Overview
13.13.3 Financial Analysis
13.13.3.1 Net Revenue, 2017-2021
13.13.3.2 R&D, 2017-2021
13.13.3.3 Regional Market Shares, 2021
13.13.4 Service Benchmarking
13.13.5 Strategic Outlook
13.14 ICON Plc
13.14.1 Company Snapshot
13.14.2 Company Overview
13.14.3 Financial Analysis
13.14.3.1 Net Revenue, 2018-2022
13.14.3.2 R&D, 2017-2021
13.14.3.3 Regional Market Shares, 2022
13.14.4 Service Benchmarking
13.14.5 Strategic Outlook
13.15 Abnova Corporation
13.15.1 Company Snapshot
13.15.2 Company Overview
13.15.3 Service Benchmarking
13.16 Vetter Pharma
13.16.1 Company Snapshot
13.16.2 Company Overview
13.16.3 Service Benchmarking
13.16.4 Strategic Outlook
13.17 Aenova Group
13.17.1 Company Snapshot
13.17.2 Company Overview
13.17.3 Financial Analysis
13.17.3.1 Net Revenue, 2017-2021
13.17.3.2 Regional Market Shares, 2021
13.17.4 Service Benchmarking
13.17.5 Strategic Outlook
13.18 Almac Group
13.18.1 Company Snapshot
13.18.2 Company Overview
13.18.3 Service Benchmarking
13.18.4 Strategic Outlook
13.19 Nipro Pharma Corporation
13.19.1 Company Snapshot
13.19.2 Company Overview
13.19.3 Financial Analysis
13.19.3.1 Net Revenue, 2018-2022
13.19.3.2 R&D, 2018-2022
13.19.3.3 Regional Market Shares, 2022
13.19.4 Service Benchmarking
13.19.5 Strategic Outlook
13.20 Jubilant Pharmova Limited
13.20.1 Company Snapshot
13.20.2 Company Overview
13.20.3 Financial Analysis
13.20.3.1 Net Revenue, 2018-2022
13.20.3.2 R&D, 2018-2022
13.20.3.3 Regional Market Shares, 2022
13.20.4 Service Benchmarking
13.20.5 Strategic Outlook
13.21 Grifols, S.A.
13.21.1 Company Snapshot
13.21.2 Company Overview
13.21.3 Financial Analysis
13.21.3.1 Net Revenue, 2018-2022
13.21.3.2 R&D, 2018-2022
13.21.3.3 Regional Market Shares, 2022
13.21.4 Service Benchmarking
13.21.5 Strategic Outlook
13.22 Pfizer Inc.
13.22.1 Company Snapshot
13.22.2 Company Overview
13.22.3 Financial Analysis
13.22.3.1 Net Revenue, 2018-2022
13.22.3.2 R&D, 2018-2022
13.22.3.3 Regional Market Shares, 2022
13.22.4 Service Benchmarking
13.22.5 Strategic Outlook
13.23 Charles River Laboratories
13.23.1 Company Snapshot
13.23.2 Company Overview
13.23.3 Financial Analysis
13.23.3.1 Net Revenue, 2017-2021
13.23.3.2 Regional Market Shares, 2021
13.23.4 Service Benchmarking
13.23.5 Strategic Outlook
13.24 IQVIA Inc.
13.24.1 Company Snapshot
13.24.2 Company Overview
13.24.3 Financial Analysis
13.24.3.1 Net Revenue, 2018-2022
13.24.3.2 R&D, 2018-2022
13.24.3.3 Regional Market Shares, 2022
13.24.4 Service Benchmarking
13.24.5 Strategic Outlook
13.25 Baxter
13.25.1 Company Snapshot
13.25.2 Company Overview
13.25.3 Financial Analysis
13.25.3.1 Net Revenue, 2018-2022
13.25.3.2 R&D, 2018-2022
13.25.3.3 Regional Market Shares, 2022
13.25.4 Service Benchmarking

14 Conclusion and Recommendations
14.1 Concluding Remarks from Visiongain
14.2 Recommendations for Market Players
?

List of Tables
Table 1 Pharmaceutical Contract Manufacturing Market Snapshot, 2022 & 2033 (US$bn, CAGR %)
Table 2 Pharmaceutical Contract Manufacturing Market by Region, 2023-2033 (US$bn, AGR (%), CAGR(%)): “V” Shaped Recovery Scenario
Table 3 Pharmaceutical Contract Manufacturing Market by Region, 2023-2033 (US$bn, AGR (%), CAGR(%)): “U” Shaped Recovery Scenario
Table 4 Pharmaceutical Contract Manufacturing Market by Region, 2023-2033 (US$bn, AGR (%), CAGR(%)): “W” Shaped Recovery Scenario
Table 5 Pharmaceutical Contract Manufacturing Market by Region, 2023-2033 (US$bn, AGR (%), CAGR(%)): “L” Shaped Recovery Scenario
Table 6 Pharmaceutical Contract Manufacturing Market Forecast by Services, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 7 Pharmaceutical Manufacturing Services Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 8 Pharmaceutical API Manufacturing Services Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 9 Pharmaceutical FDF Manufacturing Services Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 10 Parenteral/Injectable Manufacturing Services Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 11 Tablet Manufacturing Services Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 12 Capsule Manufacturing Services Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 13 Oral Liquid Manufacturing Services Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 14 Semi-solid Manufacturing Services Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 15 Other Formulation Manufacturing Services Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 16 Drug Development Services Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 17 Lead Identification & Candidate Optimization Market Forecast by Region, 2023-2033 (US$ bn)
Table 18 Target Identification & Screening Market Forecast by Region, 2023-2033 (US$ bn)
Table 19 Target Validation & Functional Informatics Market Forecast by Region, 2023-2033 (US$ bn)
Table 20 Other Services Market Forecast by Region, 2023-2033 (US$ bn)
Table 21 Biologics Manufacturing Services Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 22 Biologics API Manufacturing Services Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 23 Biologics FDF Manufacturing Services Segment Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 24 Pharmaceutical Contract Manufacturing Market by End-users, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 25 Big Pharmaceutical Companies Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 26 Small & Medium-Sized Pharmaceutical Companies Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 27 Generic Pharmaceutical Companies Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 28 Other End Users Pharmaceutical Companies Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 29 Pharmaceutical Contract Manufacturing Market Forecast by Drug Type, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 30 Branded Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 31 Generic Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 32 Pharmaceutical Contract Manufacturing Market by Region, 2023-2033 (US$bn, AGR (%), CAGR (%))
Table 33 North America Pharmaceutical Contract Manufacturing Market Forecast by Services, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 34 North America Pharmaceutical Contract Manufacturing Market Forecast by End-users 2023-2033 (US$ bn, AGR%, CAGR%)
Table 35 North America Pharmaceutical Contract Manufacturing Market Forecast by Drug Type, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 36 North America Pharmaceutical Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 37 U.S. Pharmaceutical Contract Manufacturing Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 38 Canada Pharmaceutical Contract Manufacturing Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 39 Europe Pharmaceutical Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 40 Europe Pharmaceutical Contract Manufacturing Market Forecast by Services, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 41 Europe Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 42 Europe Pharmaceutical Contract Manufacturing Market Forecast by Drug Type, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 43 Germany Pharmaceutical Contract Manufacturing Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 44 UK Pharmaceutical Contract Manufacturing Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 45 France Pharmaceutical Contract Manufacturing Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 46 Italy Pharmaceutical Contract Manufacturing Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 47 Spain Pharmaceutical Contract Manufacturing Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 48 Switzerland Pharmaceutical Contract Manufacturing Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 49 Rest of Europe Pharmaceutical Contract Manufacturing Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 50 Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 51 Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast by Services, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 52 Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 53 Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast by Drug Type, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 54 Japan Pharmaceutical Contract Manufacturing Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 55 China Pharmaceutical Contract Manufacturing Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 56 India Pharmaceutical Contract Manufacturing Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 57 Australia Pharmaceutical Contract Manufacturing Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 58 South Korea Pharmaceutical Contract Manufacturing Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 59 Rest of Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 60 Latin America Pharmaceutical Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 61 Latin America Pharmaceutical Contract Manufacturing Market Forecast by Services, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 62 Latin America Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 63 Latin America Pharmaceutical Contract Manufacturing Market Forecast by Drug Type, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 64 Brazil Pharmaceutical Contract Manufacturing Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 65 Mexico Pharmaceutical Contract Manufacturing Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 66 Rest of Latin America Pharmaceutical Contract Manufacturing Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 67 MEA Pharmaceutical Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 68 MEA Pharmaceutical Contract Manufacturing Market Forecast by Services, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 69 MEA Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 70 MEA Pharmaceutical Contract Manufacturing Market Forecast by Drug Type, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 71 GCC Pharmaceutical Contract Manufacturing Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 72 South Africa Pharmaceutical Contract Manufacturing Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 73 Rest of MEA Pharmaceutical Contract Manufacturing Market Forecast, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 74 Lonza: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 75 Lonza: Service Benchmarking
Table 76 Lonza: Strategic Outlook
Table 77 Catalent, Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 78 Catalent, Inc: Service Benchmarking
Table 79 Catalent, Inc: Strategic Outlook
Table 80 Recipharm AB: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 81 Recipharm AB: Service Benchmarking
Table 82 Recipharm AB: Strategic Outlook
Table 83 AbbVie Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 84 AbbVie Inc.: Service Benchmarking
Table 85 AbbVie Inc.: Strategic Outlook
Table 86 Thermo Fisher Scientific.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 87 Thermo Fisher Scientific.: Service Benchmarking
Table 88 Thermo Fisher Scientific Inc.: Strategic Outlook
Table 89 Siegfried Holding AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 90 Siegfried Holding AG: Service Benchmarking
Table 91 Siegfried Holding AG: Strategic Outlook
Table 92 Evonik Industries: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 93 Evonik Industries: Service Benchmarking
Table 94 Evonik Industries: Strategic Outlook
Table 95 Boehringer Ingelheim International GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 96 Boehringer Ingelheim International GmbH: Service Benchmarking
Table 97 Boehringer Ingelheim International GmbH: Strategic Outlook
Table 98 Piramal Pharma Solutions: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 99 Piramal Pharma Solutions: Service Benchmarking
Table 100 Piramal Pharma Solutions: Strategic Outlook
Table 101 Samsung Biologics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 102 Samsung Biologics: Service Benchmarking
Table 103 Samsung Biologics: Strategic Outlook
Table 104 WuXi AppTec: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 105 WuXi AppTec: Service Benchmarking
Table 106 WuXi AppTec: Strategic Outlook
Table 107 FUJIFILM Holdings Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 108 FUJIFILM Holdings Corporation: Service Benchmarking
Table 109 FUJIFILM Holdings Corporation: Strategic Outlook
Table 110 ICON Plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 111 ICON Plc. Service Benchmarking
Table 112 ICON Plc.: Strategic Outlook
Table 113 Abnova Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 114 Abnova Corporation: Service Benchmarking
Table 115 Vetter Pharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 116 Vetter Pharma: Service Benchmarking
Table 117 Vetter Pharma: Strategic Outlook
Table 118 Aenova Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 119 Aenova Group: Service Benchmarking
Table 120 Aenova Group: Strategic Outlook
Table 121 Almac Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 122 Almac Group: Service Benchmarking
Table 123 Almac Group: Strategic Outlook
Table 124 Nipro Pharma Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 125 Nipro Pharma Corporation: Service Benchmarking
Table 126 Nipro Pharma Corporation: Strategic Outlook
Table 127 Jubilant Pharmova Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 128 Jubilant Pharmova Limited: Service Benchmarking
Table 129 Jubilant Pharmova Limited: Strategic Outlook
Table 130 Grifols, S.A.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 131 Grifols, S.A: Service Benchmarking
Table 132 Grifols, S.A: Strategic Outlook
Table 133 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 134 Pfizer Inc.: Service Benchmarking
Table 135 Pfizer Inc.: Strategic Outlook
Table 136 Charles River Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 137 Charles River Laboratories: Service Benchmarking
Table 138 Charles River Laboratories: Strategic Outlook
Table 139 IQVIA Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 140 IQVIA Inc.: Service Benchmarking
Table 141 IQVIA Inc.: Strategic Outlook
Table 142 Baxter: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 143 Baxter: Service Benchmarking
?

List of Figures
Figure 1 Pharmaceutical Contract Manufacturing Market Segmentation
Figure 2 Pharmaceutical Contract Manufacturing Market: Market Dynamics
Figure 3 Pharmaceutical Contract Manufacturing Market by Region, 2023-2033 (US$ bn, AGR %): “V” Shaped Recovery
Figure 4 Pharmaceutical Contract Manufacturing Market by Region, 2023-2033 (US$ bn, AGR %): “U” Shaped Recovery
Figure 5 Pharmaceutical Contract Manufacturing Market by Region, 2023-2033 (US$ bn, AGR %): “W” Shaped Recovery
Figure 6 Pharmaceutical Contract Manufacturing Market by Region, 2023-2033 (US$ bn, AGR %): “L” Shaped Recovery
Figure 7 Pharmaceutical Contract Manufacturing Market: Porter’s Five Forces Analysis
Figure 8 Pharmaceutical Contract Manufacturing Market: PEST Analysis
Figure 9 Pharmaceutical Contract Manufacturing Market: SWOT Analysis
Figure 10 Pharmaceutical Contract Manufacturing Market Forecast by Services 2023 (Revenue, CAGR%)
Figure 11 Pharmaceutical Contract Manufacturing Market Forecast by Services, 2023-2033 (US$ bn)
Figure 12 Pharmaceutical Contract Manufacturing Market Share Forecast by Services, 2023, 2028, 2033 (%)
Figure 13 Pharmaceutical Manufacturing Services Segment Market Forecast by Region, 2023-2033 (US$ bn)
Figure 14 Pharmaceutical Manufacturing Services Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 15 Pharmaceutical API Manufacturing Services Segment Market Forecast by Region, 2023-2033 (US$ bn)
Figure 16 Pharmaceutical API Manufacturing Services Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 17 Pharmaceutical FDF Manufacturing Services Segment Market Forecast by Region, 2023-2033 (US$ bn)
Figure 18 Pharmaceutical FDF Manufacturing Services Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 19 Parenteral/Injectable Manufacturing Services Segment Market Forecast by Region, 2023-2033 (US$ bn)
Figure 20 Parenteral/Injectable Manufacturing Services Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 21 Tablet Manufacturing Services Segment Market Forecast by Region, 2023-2033 (US$ bn)
Figure 22 Tablet Manufacturing Services Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 23 Capsule Manufacturing Services Segment Market Forecast by Region, 2023-2033 (US$ bn)
Figure 24 Capsule Manufacturing Services Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 25 Oral Liquid Manufacturing Services Segment Market Forecast by Region, 2023-2033 (US$ bn)
Figure 26 Oral Liquid Manufacturing Services Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 27 Semi-solid Manufacturing Services Segment Market Forecast by Region, 2023-2033 (US$ bn)
Figure 28 Semi-solid Manufacturing Services Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 29 Other Formulation Manufacturing Services Segment Market Forecast by Region, 2023-2033 (US$ bn)
Figure 30 Other Formulation Manufacturing Services Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 31 Drug Development Services Market Forecast by Region, 2023-2033 (US$ bn)
Figure 32 Drug Development Services Market Share Forecast by Region, 2023 & 2033 (%)
Figure 33 Lead Identification & Candidate Optimization Market Forecast by Region, 2023-2033 (US$ bn)
Figure 34 Lead Identification & Candidate Optimization Market Share Forecast by Region, 2023 & 2033 (%)
Figure 35 Target Identification & Screening Market Forecast by Region, 2023-2033 (US$ bn)
Figure 36 Target Identification & Screening Market Share Forecast by Region, 2023 & 2033 (%)
Figure 37 Target Validation & Functional Informatics Market Forecast by Region, 2023-2033 (US$ bn)
Figure 38 Target Validation & Functional Informatics Market Share Forecast by Region, 2023 & 2033 (%)
Figure 39 Other Services Market Forecast by Region, 2023-2033 (US$ bn)
Figure 40 Other Services Market Share Forecast by Region, 2023 & 2033 (%)
Figure 41 Biologics Manufacturing Services Segment Market Forecast by Region, 2023-2033 (US$ bn)
Figure 42 Biologics Manufacturing Services Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 43 Biologics API Manufacturing Services Segment Market Forecast by Region, 2023-2033 (US$ bn)
Figure 44 Biologics API Manufacturing Services Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 45 Biologics FDF Manufacturing Services Segment Market Forecast by Region, 2023-2033 (US$ bn)
Figure 46 Biologics FDF Manufacturing Services Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 47 Pharmaceutical Contract Manufacturing Market by End-users 2023 (Revenue, CAGR%)
Figure 48 Pharmaceutical Contract Manufacturing Market by End-users, 2023-2033 (US$ bn)
Figure 49 Pharmaceutical Contract Manufacturing Market Share Forecast by End-users, 2023, 2028, 2033 (%)
Figure 50 Big Pharmaceutical Companies Market Forecast by Region, 2023-2033 (US$ bn)
Figure 51 Big Pharmaceutical Companies Market Share Forecast by Region, 2023 & 2033 (%)
Figure 52 Small & Medium-Sized Pharmaceutical Companies Market Forecast by Region, 2023-2033 (US$ bn)
Figure 53 Small & Medium-Sized Pharmaceutical Companies Market Share Forecast by Region, 2023 & 2033 (%)
Figure 54 Generic Pharmaceutical Companies Market Forecast by Region, 2023-2033 (US$ bn)
Figure 55 Generic Pharmaceutical Companies Market Share Forecast by Region, 2023 & 2033 (%)
Figure 56 Other End Users Pharmaceutical Companies Market Forecast by Region, 2023-2033 (US$ bn)
Figure 57 Other End Users Pharmaceutical Companies Market Share Forecast by Region, 2023 & 2033 (%)
Figure 58 Pharmaceutical Contract Manufacturing Market Forecast by Drug Type 2023 (Revenue, CAGR%)
Figure 59 Pharmaceutical Contract Manufacturing Market Forecast by Drug Type, 2023-2033 (US$ bn)
Figure 60 Pharmaceutical Contract Manufacturing Market Share Forecast by Drug Type, 2023, 2028, 2033 (%)
Figure 61 Branded Market Forecast by Region, 2023-2033 (US$ bn)
Figure 62 Branded Market Share Forecast by Region, 2023 & 2033 (%)
Figure 63 Generic Market Forecast by Region, 2023-2033 (US$ bn)
Figure 64 Generic Market Share Forecast by Region, 2023 & 2033 (%)
Figure 65 Pharmaceutical Contract Manufacturing Market Forecast by Region 2023, 2028, 2033 (Revenue, CAGR%)
Figure 66 Pharmaceutical Contract Manufacturing Market Share Forecast by Region 2023, 2028, 2033(%)
Figure 67 Pharmaceutical Contract Manufacturing Market by Region, 2023-2033 (US$ bn, AGR %)
Figure 68 North America Pharmaceutical Contract Manufacturing Market Attractiveness Index
Figure 69 North America Pharmaceutical Contract Manufacturing Market Forecast by Services, 2023-2033 (US$ bn)
Figure 70 North America Pharmaceutical Contract Manufacturing Market Share Forecast by Services, 2023 & 2033 (%)
Figure 71 North America Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2023-2033 (US$ bn)
Figure 72 North America Pharmaceutical Contract Manufacturing Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 73 North America Pharmaceutical Contract Manufacturing Market Forecast by Drug Type, 2023-2033 (US$ bn)
Figure 74 North America Pharmaceutical Contract Manufacturing Market Share Forecast by Drug Type, 2023 & 2033 (%)
Figure 75 North America Pharmaceutical Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ bn)
Figure 76 North America Pharmaceutical Contract Manufacturing Market Share Forecast by Country, 2023 & 2033 (%)
Figure 77 U.S. Pharmaceutical Contract Manufacturing Market Forecast, 2023-2033 (US$ bn, AGR %)
Figure 78 Canada Pharmaceutical Contract Manufacturing Market Forecast, 2023-2033 (US$ bn, AGR %)
Figure 79 Europe Pharmaceutical Contract Manufacturing Market Attractiveness Index
Figure 80 Europe Pharmaceutical Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ bn)
Figure 81 Europe Pharmaceutical Contract Manufacturing Market Share Forecast by Country, 2023 & 2033 (%)
Figure 82 Europe Pharmaceutical Contract Manufacturing Market Forecast by Service, 2023-2033 (US$ bn)
Figure 83 Europe Pharmaceutical Contract Manufacturing Market Share Forecast by Services, 2023 & 2033 (%)
Figure 84 Europe Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2023-2033 (US$ bn)
Figure 85 Europe Pharmaceutical Contract Manufacturing Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 86 Europe Pharmaceutical Contract Manufacturing Market Forecast by Drug Type, 2023-2033 (US$ bn)
Figure 87 Europe Pharmaceutical Contract Manufacturing Market Share Forecast by Drug Type, 2023 & 2033(%)
Figure 88 Germany Pharmaceutical Contract Manufacturing Market Forecast, 2023-2033 (US$ bn, AGR %)
Figure 89 UK Pharmaceutical Contract Manufacturing Market Forecast, 2023-2033 (US$ bn, AGR %)
Figure 90 France Pharmaceutical Contract Manufacturing Market Forecast, 2023-2033 (US$ bn, AGR %)
Figure 91 Italy Pharmaceutical Contract Manufacturing Market Forecast, 2023-2033 (US$ bn, AGR %)
Figure 92 Spain Pharmaceutical Contract Manufacturing Market Forecast, 2023-2033 (US$ bn, AGR %)
Figure 93 Switzerland Pharmaceutical Contract Manufacturing Market Forecast, 2023-2033 (US$ bn, AGR %)
Figure 94 Rest of Europe Pharmaceutical Contract Manufacturing Market Forecast, 2023-2033 (US$ bn, AGR %)
Figure 95 Asia Pacific Pharmaceutical Contract Manufacturing Market Attractiveness Index
Figure 96 Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ bn)
Figure 97 Asia Pacific Pharmaceutical Contract Manufacturing Market Share Forecast by Country, 2023 & 2033 (%)
Figure 98 Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast by Services, 2023-2033 (US$ bn)
Figure 99 Asia Pacific Pharmaceutical Contract Manufacturing Market Share Forecast by Services, 2023 & 2033 (%)
Figure 100 Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2023-2033 (US$ bn)
Figure 101 Asia Pacific Pharmaceutical Contract Manufacturing Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 102 Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast by Drug Type, 2023-2033 (US$ bn)
Figure 103 Asia Pacific Pharmaceutical Contract Manufacturing Market Share Forecast by Drug Type, 2023 & 2033 (%)
Figure 104 Japan Pharmaceutical Contract Manufacturing Market Forecast, 2023-2033 (US$ bn, AGR %)
Figure 105 China Pharmaceutical Contract Manufacturing Market Forecast, 2023-2033 (US$ bn, AGR %)
Figure 106 India Pharmaceutical Contract Manufacturing Market Forecast, 2023-2033 (US$ bn, AGR %)
Figure 107 Australia Pharmaceutical Contract Manufacturing Market Forecast, 2023-2033 (US$ bn, AGR %)
Figure 108 South Korea Pharmaceutical Contract Manufacturing Market Forecast, 2023-2033 (US$ bn, AGR %)
Figure 109 Rest of Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast, 2023-2033 (US$ bn, AGR %)
Figure 110 Latin America Pharmaceutical Contract Manufacturing Market Attractiveness Index
Figure 111 Latin America Pharmaceutical Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ bn)
Figure 112 Latin America Pharmaceutical Contract Manufacturing Market Share Forecast by Country, 2023 & 2033 (%)
Figure 113 Latin America Pharmaceutical Contract Manufacturing Market Forecast by Services, 2023-2033 (US$ bn)
Figure 114 Latin America Pharmaceutical Contract Manufacturing Market Share Forecast by Services, 2023 & 2033 (%)
Figure 115 Latin America Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2023-2033 (US$ bn)
Figure 116 Latin America Pharmaceutical Contract Manufacturing Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 117 Latin America Pharmaceutical Contract Manufacturing Market Forecast by Drug Type, 2023-2033 (US$ bn)
Figure 118 Latin America Pharmaceutical Contract Manufacturing Market Share Forecast by Drug Type, 2023 & 2033 (%)
Figure 119 Brazil Pharmaceutical Contract Manufacturing Market Forecast, 2023-2033 (US$ bn, AGR %)
Figure 120 Mexico Pharmaceutical Contract Manufacturing Market Forecast, 2023-2033 (US$ bn, AGR %)
Figure 121 Rest of Latin America Pharmaceutical Contract Manufacturing Market Forecast, 2023-2033 (US$ bn, AGR %)
Figure 122 MEA Pharmaceutical Contract Manufacturing Market Attractiveness Index
Figure 123 MEA Pharmaceutical Contract Manufacturing Market by Region, 2023, 2028 & 2033 (US$ bn)
Figure 124 MEA Pharmaceutical Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ bn)
Figure 125 MEA Pharmaceutical Contract Manufacturing Market Share Forecast by Country, 2023 & 2033 (%)
Figure 126 MEA Pharmaceutical Contract Manufacturing Market Forecast by Services, 2023-2033 (US$ bn)
Figure 127 MEA Pharmaceutical Contract Manufacturing Market Share Forecast by Services, 2023 & 2033 (%)
Figure 128 MEA Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2023-2033 (US$ bn)
Figure 129 MEA Pharmaceutical Contract Manufacturing Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 130 MEA Pharmaceutical Contract Manufacturing Market Forecast by Drug Type, 2023-2033 (US$ bn)
Figure 131 MEA Pharmaceutical Contract Manufacturing Market Share Forecast by Drug Type, 2023 & 2033 (%)
Figure 132 GCC Pharmaceutical Contract Manufacturing Market Forecast, 2023-2033 (US$ bn, AGR %)
Figure 133 South Africa Pharmaceutical Contract Manufacturing Market Forecast, 2023-2033 (US$ bn, AGR %)
Figure 134 Rest of MEA Pharmaceutical Contract Manufacturing Market Forecast, 2023-2033 (US$ bn, AGR %)
Figure 135 Pharmaceutical Contract Manufacturing Market: Company Share, 2022
Figure 136 Lonza: Net Revenue, 2018-2022 (US$ million, AGR%)
Figure 137 Catalent, Inc: Net Revenue, 2018-2022 (US$ million, AGR%)
Figure 138 Catalent, Inc: Regional Market Shares, 2022
Figure 139 Recipharm AB: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 140 AbbVie Inc.: Net Revenue, 2018-2022 (US$ million, AGR%)
Figure 141 AbbVie Inc.: R&D, 2018-2022 (US$ million, AGR%)
Figure 142 AbbVie Inc.: Regional Market Shares, 2022
Figure 143 Thermo Fisher Scientific.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 144 Thermo Fisher Scientific.: R&D, 2017-2021 (US$ million, AGR%)
Figure 145 Thermo Fisher Scientific.: Regional Market Shares, 2021
Figure 146 Siegfried Holding AG: Net Revenue, 2018-2022 (US$ million, AGR%)
Figure 147 Siegfried Holding AG: R&D, 2018-2022 (US$ million, AGR%)
Figure 148 Evonik Industries: Net Revenue, 2018-2022(US$ million, AGR%)
Figure 149 Evonik Industries: R&D, 2018-2022 (US$ million, AGR%)
Figure 150 Evonik Industries: Regional Market Shares, 2022
Figure 151 Boehringer Ingelheim International GmbH: Net Revenue, 2017-2021(US$ million, AGR%)
Figure 152 Boehringer Ingelheim International GmbH: R&D, 2017-2021 (US$ million, AGR%)
Figure 153 Boehringer Ingelheim International GmbH: Regional Market Shares, 2021
Figure 154 Samsung Biologics: Net Revenue, 2017-2021(US$ million, AGR%)
Figure 155 Samsung Biologics: Regional Market Shares, 2021
Figure 156 WuXi AppTec: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 157 FUJIFILM Holdings Corporation: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 158 FUJIFILM Holdings Corporation: R&D, 2017-2021 (US$ million, AGR%)
Figure 159 FUJIFILM Holdings Corporation: Regional Market Shares, 2021
Figure 160 ICON Plc: Net Revenue, 2018-2022 (US$ million, AGR%)
Figure 161 ICON Plc: R&D, 2017-2021 (US$ million, AGR%)
Figure 162 ICON Plc: Regional Market Shares, 2022
Figure 163 Aenova Group: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 164 Aenova Group: Regional Market Shares, 2021
Figure 165 Nipro Pharma Corporation: Net Revenue, 2018-2022 (US$ million, AGR%)
Figure 166 Nipro Pharma Corporation: R&D, 2018-2022 (US$ million, AGR%)
Figure 167 Nipro Pharma Corporation: Regional Market Shares, 2022
Figure 168 Jubilant Pharmova Limited: Net Revenue, 2018-2022 (US$ million, AGR%)
Figure 169 Jubilant Pharmova Limited: R&D, 2018-2022 (US$ million, AGR%)
Figure 170 Jubilant Pharmova Limited: Regional Market Shares, 2022
Figure 171 Grifols, S.A: Net Revenue, 2018-2022 (US$ million, AGR%)
Figure 172 Grifols, S.A: R&D, 2018-2022 (US$ million, AGR%)
Figure 173 Grifols, S.A: Regional Market Shares, 2022
Figure 174 Pfizer Inc: Net Revenue, 2018-2022 (US$ million, AGR%)
Figure 175 Pfizer Inc.: R&D, 2018-2022 (US$ million, AGR%)
Figure 176 Pfizer Inc: Regional Market Shares, 2022
Figure 177 Charles River Laboratories: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 178 Charles River Laboratories: Regional Market Shares, 2021
Figure 179 IQVIA Inc.: Net Revenue, 2018-2022 (US$ million, AGR%)
Figure 180 IQVIA Inc.: R&D, 2018-2022 (US$ million, AGR%)
Figure 181 IQVIA Inc.: Regional Market Shares, 2022
Figure 182 Baxter: Net Revenue, 2018-2022 (US$ million, AGR%)
Figure 183 Baxter: R&D, 2018-2022 (US$ million, AGR%)
Figure 184 Baxter: Regional Market Shares, 2022